Publications

No detectable differences in Nef-mediated downregulation of HLA-I and CD4 molecules among HIV-1 group M lineages circulating in Cameroon, where the pandemic originated

Front Virol

This study examines the behavior of a specific HIV-1 protein called Nef in various strains of the virus found in Cameroon, where the HIV pandemic is believed to have originated. The Nef protein plays a crucial role in helping the HIV virus evade the immune system. It does this by reducing the levels of certain molecules on the surface of infected cells, specifically HLA-I and CD4 molecules. HLA-I molecules are important for the immune system to recognize and attack infected cells, while CD4 molecules are the primary targets of HIV infection. The researchers investigated whether different lineages (genetic variations) of HIV-1 Group M, the most common group of HIV strains, show any differences in how effectively their Nef proteins can downregulate HLA-I and CD4 molecules. This was done by analyzing samples from individuals in Cameroon. The key finding is that there were no detectable differences in the ability of the Nef protein to downregulate HLA-I and CD4 among the various HIV-1 Group M lineages circulating in Cameroon. This suggests that, despite genetic variations, these strains of the virus have a similar capacity to evade the immune system using the Nef protein. In summary, this research shows that different strains of HIV-1 in Cameroon have similar capabilities in using the Nef protein to decrease levels of key immune molecules, aiding in their ability to evade the immune response. This understanding is important for developing treatments and vaccines that target this viral evasion mechanism.

SANTHE is an Africa Health Research Institute (AHRI) flagship programme funded by the Science for Africa Foundation through the DELTAS Africa programme; the Bill & Melinda Gates Foundation; Gilead Sciences Inc.; and the Ragon Institute of Mass General, MIT, and Harvard.